Bristol-Myers Squibb Surges on Acquisition News; Tyson Falls on 3Q Sales Shortfall
Macro·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Bristol-Myers Squibb (SQB) shares are surging on news AstraZeneca (AZN), whose shares are lower, is exploring an acquisition of Bristol-Myers Squibb.
Tyson (TSN) shares are dropping after the protein producer reported a 3Q sales shortfall, driven by a 16% reduction.
Bristol-Myers SquibbAstraZenecaTyson
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“On this episode of Stock Movers:”
Bloomberg — Tyson Falls on 3Q Results; Bristol-Myers Squibb Surges on Potential Acquisition | Stock Movers